237 related articles for article (PubMed ID: 33099310)
1. Metreleptin for the treatment of progressive encephalopathy with/without lipodystrophy (PELD) in a child with progressive myoclonic epilepsy: a case report.
Pedicelli S; de Palma L; Pelosini C; Cappa M
Ital J Pediatr; 2020 Oct; 46(1):158. PubMed ID: 33099310
[TBL] [Abstract][Full Text] [Related]
2. A Report of Three Cases With Acquired Generalized Lipodystrophy With Distinct Autoimmune Conditions Treated With Metreleptin.
Lebastchi J; Ajluni N; Neidert A; Oral EA
J Clin Endocrinol Metab; 2015 Nov; 100(11):3967-70. PubMed ID: 26390101
[TBL] [Abstract][Full Text] [Related]
3. Celia's encephalopathy and c.974dupG in BSCL2 gene: a hidden change in a known variant.
Sánchez-Iglesias S; Crocker M; O'Callaghan M; Darling A; García-Cazorla A; Domingo-Jiménez R; Castro A; Fernández-Pombo A; Ruibal Á; Aguiar P; Garrido-Pumar M; Rodríguez-Núñez A; Álvarez-Escudero J; Brown RJ; Araújo-Vilar D
Neurogenetics; 2019 May; 20(2):73-82. PubMed ID: 30903322
[TBL] [Abstract][Full Text] [Related]
4. Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the
Özalkak Ş; Demiral M; Ünal E; Taş FF; Onay H; Demirbilek H; Özbek MN
J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):329-333. PubMed ID: 35735786
[TBL] [Abstract][Full Text] [Related]
5. Berardinelli-Seip syndrome and progressive myoclonus epilepsy.
Serino D; Davico C; Specchio N; Marras CE; Fioretto F
Epileptic Disord; 2019 Feb; 21(1):117-121. PubMed ID: 30767895
[TBL] [Abstract][Full Text] [Related]
6. Association of metreleptin treatment and dietary intervention with neurological outcomes in Celia's encephalopathy.
Araújo-Vilar D; Domingo-Jiménez R; Ruibal Á; Aguiar P; Ibáñez-Micó S; Garrido-Pumar M; Martínez-Olmos MÁ; López-Soler C; Guillín-Amarelle C; González-Rodríguez M; Rodríguez-Núñez A; Álvarez-Escudero J; Liñares-Paz M; González-Méndez B; Rodríguez-García S; Sánchez-Iglesias S
Eur J Hum Genet; 2018 Mar; 26(3):396-406. PubMed ID: 29367704
[TBL] [Abstract][Full Text] [Related]
7. Clinical effects of long-term metreleptin treatment in patients with lipodystrophy.
Chan JL; Lutz K; Cochran E; Huang W; Peters Y; Weyer C; Gorden P
Endocr Pract; 2011; 17(6):922-32. PubMed ID: 22068254
[TBL] [Abstract][Full Text] [Related]
8. Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin.
Diker-Cohen T; Cochran E; Gorden P; Brown RJ
J Clin Endocrinol Metab; 2015 May; 100(5):1802-10. PubMed ID: 25734254
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience.
Araujo-Vilar D; Sánchez-Iglesias S; Guillín-Amarelle C; Castro A; Lage M; Pazos M; Rial JM; Blasco J; Guillén-Navarro E; Domingo-Jiménez R; del Campo MR; González-Méndez B; Casanueva FF
Endocrine; 2015 May; 49(1):139-47. PubMed ID: 25367549
[TBL] [Abstract][Full Text] [Related]
10. Monogenic forms of lipodystrophic syndromes: diagnosis, detection, and practical management considerations from clinical cases.
Vatier C; Vantyghem MC; Storey C; Jéru I; Christin-Maitre S; Fève B; Lascols O; Beltrand J; Carel JC; Vigouroux C; Bismuth E
Curr Med Res Opin; 2019 Mar; 35(3):543-552. PubMed ID: 30296183
[TBL] [Abstract][Full Text] [Related]
11. Effects of Metreleptin in Pediatric Patients With Lipodystrophy.
Brown RJ; Meehan CA; Cochran E; Rother KI; Kleiner DE; Walter M; Gorden P
J Clin Endocrinol Metab; 2017 May; 102(5):1511-1519. PubMed ID: 28324110
[TBL] [Abstract][Full Text] [Related]
12. Metreleptin Treatment in Patients with Non-HIV Associated Lipodystrophy.
Akinci G; Akinci B
Recent Pat Endocr Metab Immune Drug Discov; 2015; 9(2):74-8. PubMed ID: 26556498
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy.
Nagayama A; Ashida K; Watanabe M; Moritaka K; Sonezaki A; Kitajima Y; Takahashi H; Yoshinobu S; Iwata S; Yasuda J; Hasuzawa N; Ozono S; Motomura S; Nomura M
Front Endocrinol (Lausanne); 2021; 12():690996. PubMed ID: 34135866
[TBL] [Abstract][Full Text] [Related]
14. New advances in the treatment of generalized lipodystrophy: role of metreleptin.
Rodriguez AJ; Mastronardi CA; Paz-Filho GJ
Ther Clin Risk Manag; 2015; 11():1391-400. PubMed ID: 26396524
[TBL] [Abstract][Full Text] [Related]
15. Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.
Meehan CA; Cochran E; Kassai A; Brown RJ; Gorden P
Expert Rev Clin Pharmacol; 2016; 9(1):59-68. PubMed ID: 26465174
[TBL] [Abstract][Full Text] [Related]
16. Focus on progressive myoclonic epilepsy in Berardinelli-Seip syndrome.
Ferranti S; Lo Rizzo C; Renieri A; Galluzzi P; Grosso S
Neurol Sci; 2020 Nov; 41(11):3345-3348. PubMed ID: 32440981
[TBL] [Abstract][Full Text] [Related]
17. Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy.
Brown RJ; Oral EA; Cochran E; Araújo-Vilar D; Savage DB; Long A; Fine G; Salinardi T; Gorden P
Endocrine; 2018 Jun; 60(3):479-489. PubMed ID: 29644599
[TBL] [Abstract][Full Text] [Related]
18. Medical management of a child with congenital generalized lipodystrophy accompanied with progressive myoclonic epilepsy: A case report.
Zhang Y; Chen X; Luo F; Jiang L; Xu J; Chen S
Medicine (Baltimore); 2019 Nov; 98(48):e18121. PubMed ID: 31770241
[TBL] [Abstract][Full Text] [Related]
19. One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes.
Vatier C; Fetita S; Boudou P; Tchankou C; Deville L; Riveline J; Young J; Mathivon L; Travert F; Morin D; Cahen J; Lascols O; Andreelli F; Reznik Y; Mongeois E; Madelaine I; Vantyghem M; Gautier J; Vigouroux C
Diabetes Obes Metab; 2016 Jul; 18(7):693-7. PubMed ID: 26584826
[TBL] [Abstract][Full Text] [Related]
20. Lymphoma in acquired generalized lipodystrophy.
Brown RJ; Chan JL; Jaffe ES; Cochran E; DePaoli AM; Gautier JF; Goujard C; Vigouroux C; Gorden P
Leuk Lymphoma; 2016; 57(1):45-50. PubMed ID: 25864863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
